Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole (D961H) in Japanese Pediatric Patients with Acid-Related Diseases
NCT02153398Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in gastric ulcer, duodenal ulcer, anastomotic ulcer, non-erosive reflux disease (NERD), reflux esophagitis, sponsored by AstraZeneca. Started Jun 2014; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastric ulcerduodenal ulceranastomotic ulcernon-erosive reflux disease (NERD)reflux esophagitis
Beyond the preview
Go deeper on NCT02153398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153398.